All Insights
Showing 25 - 36 of 239
Knowledge Notes
Reviewing our UK business law predictions for 2023: how are we doing at the half-way point?
We examine how our predictions have turned out in practice, and what to watch out for as autumn draws nearer
Brexit
The Retained EU Law Act 2023: the revolution is cancelled, but substantive change to UK law post-Brexit continues
Fundamental principles of EU law removed, broad ministerial powers granted and a limited 'sunset' of retained law
Regulatory Outlook
Products | UK Regulatory Outlook June 2023
General Product Safety Regulation enters into force | Council of the EU adopt position on new Product Liability Directive |
Regulatory Outlook
Health and safety | UK Regulatory Outlook May 2023
UK government publishes draft legislation on the protect duty | HSE launches inspection initiative into respiratory health for the construction
Regulatory Outlook
Food Law | UK Regulatory Outlook May 2023
FSA commission review of novel food framework | How will the Retained EU Law Bill affect UK and international businesses?
Employment and pensions
Employment Law Coffee Break | Reforms to working time, TUPE and non-competes; stress in the workplace; and an update from our incentives team
Welcome to our latest Coffee Break in which we look at the latest legal and practical developments impacting employers
Brexit
How will the Retained EU Law Bill affect UK and international businesses?
A slow passage in Parliament has added to uncertainty as businesses and their risk managers look to prepare for change
Intellectual property
UK sets out the new Science and Technology Framework
Government growth ambitions for critical technologies including AI and future telecoms require regulatory clarity
Employment and pensions
What effect will the Spring Budget 2023 have on UK immigration?
Policy to simplify business visitor rules may enable visitors to conduct a wider range of business activities in the UK
Life Sciences and Healthcare
Spring Budget 2023 | UK chancellor announces new regulatory model for medicines and medical technologies
Move raises the question of whether regulatory framework for medicines and medical devices will diverge from the EU model in
Dispute resolution
Choice of courts: Are asymmetric jurisdiction clauses still a good idea post-Brexit?
Asymmetric jurisdiction clauses bring with them new risks in an EU context, to be weighed on a deal-by-deal basis –
Regulatory Outlook
Health and safety | UK Regulatory Outlook February 2023
Developers given six weeks to sign contract to fix unsafe buildings | Risks posed by falling trees | Building Safety
